Researchers at the University of Missouri found that diet and exercise can significantly improve liver disease caused by too ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

A New 3D Bioprinted Model Offers a Novel Tool to Study Common Liver Disease, and Perhaps Find an Effective Treatment Jan. 23, 2024 — Metabolic dysfunction--associated steatohepatitis or MASH ...

Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. The London-based biotechnology company ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...